Experimental virus drug Remdesivir failed in COVID-19 human trial – Reports
The experimental antiviral drug remdesivir has failed in its first randomized clinical trial to treat the COVID-19 illness, reports said Thursday, quoting draft documents that were accidentally published by the World Health Organization.
Gilead Sciences, the company behind the medicine, disputed how the now deleted post had characterized the findings, saying the data showed a “potential benefit.”
The Financial Times reported that researchers in China carried out a study on 237 patients, giving the drug to 158 and comparing their progress with a control group of 79.
A summary of the experiment said remdesivir was “not associated with a difference in time to clinical improvement” compared to the control, according to health news site Stat, which posted a screenshot.
After a month, 13.9 percent of the patients on remdesivir had died compared to 12.8 percent of those in the control group.
A spokesman for Gilead told AFP: “We believe the post included inappropriate characterizations of the study,” saying it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” he said.
The study does not represent the final word on the matter and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs mooted as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes for Health also reported it had proven effective in a small experiment on monkeys.
Remdesivir belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes.
It mimics one of the four building blocks of RNA and DNA and gets absorbed into the virus’s genome, which in turn stops the pathogen from replicating.
2022 World Cup: Saudi Arabia beat Argentina 2-1
Saudi Arabia recorded the first major upset of the World Cup as they beat Argentina 2-1 in their opening game...
2023: Lai Mohammed accuses opposition parties of using fake news in campaigns against APC
The Federal Government has accused opposition parties of using fake news and disinformation to prosecute the campaigns towards the 2023...
Twitter Restores Donald Trump’s Account
Microblogging service Twitter has reinstated former United States President Donald Trump’s account. The account was restored after Twitter’s new owner...
How Sabinus scammed me of N2m – Event planner cries out
An event planner, Johnbosco Ezeuchegbu aka Crazylegs, on Friday called out a popular comedian, Chukwuemeka Emmanuel, also known as Sabinus,...
Identity Of Humanitarian Worker Killed By Trigger-Happy Soldier Revealed
The identity of the humanitarian worker shot by a soldier in Damboa Local Government Area of Borno State has been...
Ghana finance minister apologises for economic hardship
Ghana’s Finance Minister Ken Ofori-Atta on Friday said he was “truly sorry” for the country’s economic hardships but defended himself...
Youth minister confirms sack of NYSC DG
The Minister of Youth and Sports Development Sunday Dare has confirmed the removal of the Director-General of the National Youth...
Naira redesign: Give us more time – Miyetti Allah cries out to CBN
The leader of the Miyetti Allah Cattle Breeders Association of Nigeria, MCBAN, South-East Chapter, has appealed to the Central Bank of...
We’ll dialogue with IPOB, others – Tinubu
All Progressives Congress (APC) presidential candidate, Asiwaju Bola Ahmed Tinubu has said his government will discuss with all agitating groups...
Buhari fires DG NYSC 6 months after assuming office
President Muhammadu Buhari has approved the immediate removal of Brigadier-General Muhammad Kukah Fadah, from office as the Director General of...